Summary
Despite many proven advances in patient care over the last 10 years, asthma continues to impose a large and growing burden on society. Persistent clinician non-adherence to recommended practice is well documented, but little is known about the clinical impact and economic costs of alternative approaches to asthma patient care. In this chapter, we introduce the Asthma Policy Model, a state-transition simulation that we have developed to forecast asthma-related symptoms, acute exacerbations, quality-adjusted life expectancy, health care costs, and cost-effectiveness. We begin with a detailed survey of the epidemiological, clinical, and policy context that motivates our work. With a modeling audience in mind, we then describe the considerations that produced the current analytic structure and input datasets. We illustrate the policy relevance of the model by describing our recent work on the cost-effectiveness of inhaled corticosteroid therapy in a population of adult patients with mild-to-moderate disease. We close the chapter with a discussion of plans for future refinements and applications.
Key words
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
National Asthma Education and Prevention Program (1997). Guidelines for the Diagnosis and Management of Asthma. Expert Panel Report 2, Publication # 97-4051, U.S. Department of Health and Human Services, Washington, DC.
Mack, H., P. Johnson, H. Abbey, and R.C. Talcerno (1982). Prevalence of asthma and health service utilization of asthmatic children in a inner city. Journal of Allergy and Clinical Immunology, 70, 367–372.
Halfon, N. and P.W. Newacheck (1986). Trends in the hospitalization of acute childhood asthma, 1970–1984. American Journal of Public Health, 76, 1308–1311.
Evans, R. 3rd, D.E. Mullally, R.W. Wilson, P.J. Gergen, H.M. Rosenberg, J.S. Grauman, F.M. Chevarley, and M. Feinleib (1987). National trends in the morbidity and mortality of asthma in the US. Prevalence, hospitalization, and death from asthma over two decades: 1965–1984. Chest, 91, 65S–74S.
Sly, R.M. (1988). Mortality from asthma, 1979–1984. Journal of Allergy and Clinical Immunology, 82, 705–717.
Weiss, K.B., P.J. Gergen, and E.F. Crain (1992). Inner-city asthma. The epidemiology of an emerging US public health concern. Chest, 101, 362S–367S.
National Heart, Lung, and Blood Institute (2000). Morbidity and Mortality: 2000 Chart Book on Cardiovascular, Lung, and Blood Diseases. National Institutes of Health, Bethesda, MD.
Marder, D., P. Targonski, P. Orris, V. Persky, and W. Addington (1992). Effect of racial and socioeconomic factors on asthma mortality in Chicago. Chest, 101, 4265S–4429S.
Carr, W., L. Zeitel, and K.B. Weiss (1992). Asthma hospitalization and mortality in New York City. American Journal of Public Health, 82, 59–65.
Martinez, F.D., A.L. Wright, L.M. Taussig, C.J. Holberg, M. Halonen, and W.J. Morgan (1995). Asthma and wheezing in the first six years of life. The Group Health Medical Associates. New England Journal of Medicine, 332, 133–138.
Kattan, M., H. Mitchell, P. Eggleston, P. Gergen, E. Crain, S. Redline, K. Weiss, R. Evans 3rd, R. Kaslow, C. Kercsmar, F. Leickly, F. Malveaux, and H.J. Wedner (1997). Characteristics of inner-city children with asthma: The National Cooperative Inner-City Asthma Study. Pediatric Pulmonology, 24, 253–262.
Kitch, B.T., G. Chew, H.A. Burge, M.L. Muilenberg, S.T. Weiss, T.A. Platts-Mills, G. O’Connor and D.R. Gold (2000). Socioeconomic predictors of high allergen levels in homes in the greater Boston area. Environmental Health Perspectives, 108, 301–307.
Evans, R. (1992). Asthma among minority children. A growing problem. Chest, 101(Suppl), 368S–371S.
Gottlieb, D.J., A.S. Beiser, and G.T. O’Connor (1995). Poverty, race, and medication use are correlates of asthma hospitalization rates. A small area analysis in Boston. Chest, 108, 28–35.
Weiss, K.B., E.N. Grant, and T. Li (1999). The effects of asthma experience and social demographic characteristics on responses to the Chicago Community Asthma Survey-32. Chicago Asthma Surveillance Initiative Project Team. Chest, 116(Suppl 1), 183S–189S.
Stableforth, D.E. (1987). Asthma mortality and physician competence. Journal of Allergy and Clinical Immunology, 80, 463–466.
Kravis, L.P. (1987). An analysis of fifteen childhood asthma fatalities. Journal of Allergy and Clinical Immunology, 80, 467–472.
Strunk, R.C., D.A. Mrazek, G.S.W. Fuhrmann, and J.F. LaBrecque (1985). Deaths from asthma in childhood. Can they be predicted? Journal of the American Medical Association, 254, 1193.
Barnes, P.J. (1989). A new approach to the treatment of asthma. Department of Thoracic Medicine, Brompton Hospital, London, United Kingdom. New England Journal of Medicine, 321, 1517–1527.
Barnes, P.J. and I. Adcock (1993). Anti-inflammatory actions of steroids: molecular mechanisms. Trends in Pharmacological Sciences, 14, 436–441
Pearlman, D.S., P. Chervinsky, C. LaForce, J.M. Seltzer, D.L. Southern, J.P. Kemp, RJ. Dockhorn, J. Grossman, R.F. Liddle, and S.W. Yancey (1992). A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. New England Journal of Medicine, 327, 1420–1425.
Henderson, W.R., Jr. (1994). Role of leukotrienes in asthma. Annals of Allergy, 72, 272–278.
Buchner, D.A., L.T. Butt, A. De Stefano, B. Edgren, A. Suarez, and R.M. Evans (1998). Effects of an asthma management program of the asthmatic member: Patient centered results of a 2 year study in a managed care organization. American Journal of Managed Care, 4, 1288–1297.
Hammarquist, C., M.L. Burr, and P.C. Gotzsche for the Cochrane Airways Group (2001). House dust mite control measures for asthma. Cochrane Database of Systematic Reviews, Issue 1.
Peat, J.K. and J. Li (1999). Reversing the trend: Reducing the prevalence of asthma. Journal of Allergy and Clinical Immunology, 130, 1–10.
Custovic, A., S.C.O. Taggart, H.C. Francis, M.D. Chapman, and A. Woodcock (1995). Exposure to house dust mite allergens and the clinical activity of asthma. Journal of Allergy and Clinical Immunology, 98, 64–72.
Durham, S.R. (1996). Allergen avoidance measures. British Thoracic Society. Respiratory Medicine, 90, 441–5.
Watson, W.T.A., A.B. Becker, and F.E.R. Simons (1993). Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness. Journal of Allergy and Clinical Immunology, 91, 97–101.
Pedersen, B., R. Dahl, N. Lindqvist, and N. Mygind (1990). Nasal inhalation of the glucocorticoid budesonide from a spacer for the treatment of patients with pollen rhinitis and asthma. Allergy, 45, 451–456.
Grant, J.A., C.F. Nicodemus, S.R. Findlay, MM. Glovsky, J. Grossman, H. Kaiser, E.O. Meltzer, D.Q. Mitchell, D. Pearlman, and J. Selner (1995). Clinical aspects of allergic disease. Cetrizine in patients with seasonal rhinitis and concomitant asthma: prospective, randomized, placebo-controlled trial. Journal of Allergy and Clinical Immunology, 95, 923–932.
Corren, J., A. Harris, D. Aaronson, W. Beaucher, R. Berkowitz, E. Bronsky, R. Chen, P. Chervinsky, R. Cohen, J. Fourre, J. Grossman, E. Meltzer, A. Pedinoff, W. Strieker, and A. Wanderer (1997). Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma. Journal of Allergy and Clinical Immunology, 100, 781–788.
Parmley, W.W. (1994). Clinical practice guidelines: does the cookbook have enough recipes? Journal of the American Medical Association, 272, 1374–1375.
Ellrodt, A.G., L. Conner, M. Riedinger, and S. Weingarten (1995). Measuring and improving physician compliance with clinical practice guidelines: a controlled interventional trial. Annals of Internal Medicine, 122, 277–282.
Grimshaw, K., N. Freemantle, S. Wallace, I. Russell, B. Herwitz, I. Watt, A. Long, and T. Sheldon (1995). Developing and implementing clinical practice guidelines. Quality in Health Care, 4, 55–64.
Adams, R.J., A. Fuhlbrigge, T. Guilbert, P. Lozano, and F. Martinez (2002). Inadequate use of asthma medication in the United States: results of the asthma in America national population survey. Journal of Allergy and Clinical Immunology, 110, 58–64.
Windsor, R.A., W.C. Bailey, J.M. Richards Jr., B. Manzella, S.J. Soong, and M. Brooks (1990). Evaluation of the efficacy and cost-effectiveness of health education methods to increase medication adherence among adults with asthma. American Journal of Public Health, 80, 1519.
Gallefoss, F. and P.S. Bakke (2001). Cost-effectiveness of self-management in asthmatics: a 1-yr follow-up randomized, controlled trial. European Respiratory Journal, 17, 206–213.
Wilson Pessano, S.R., P. Scamagas, G.M. Arsham, L. Chardon, S. Coss, D.F. German, and G.W. Hughes (1987). An evaluation of approaches to asthma self-management education for adults: the AIR/Kaiser Permanente study. Journal of Health Education, 14, 333–343.
Clark, N.M., C.H. Feldman, D. Evans, M.J. Levison, Y. Wasilewski, and R.B. Mellins (1986). The impact of health education on frequency and cost of health care use by low income children with asthma. Journal of Allergy and Clinical Immunology, 78, 108–115.
Lewis, C.E., G. Rachelefsky, M.A. Lewis, A de la Sota, and M. Kaplan (1984). A randomized trial of A.C.T. (asthma care training) for kids. Pediatrics, 74, 478–486.
Tierce, J.C., W. Meller, B. Berlow, and W.C. Gerth (1989). Assessing the cost of albuterol inhalers in the Michigan and California Medicaid programs: a total cost-of-care approach. Clinical Therapeutics, 11, 53.
Campbell, L.M., R.J. Simpson, M.L. Turbitt, and P.D.I. Richardson (1993). A comparison of the cost-effectiveness of budesonide 400 mg/day and 800 mg/day in the management of mild-to-moderate asthma in general practice. British Journal of Medical Economics, 6, 67–74.
Ross, R.N., M. Morris, S.R. Sakowitz, and B.A. Berman (1988). Cost-effectiveness of including cromolyn sodium in the treatment program for asthma: a retrospective, record based study. Clinical Therapeutics, 10, 188–203.
Rutten-van-Molken, M.P.M.H., E.K.A. Van Doorslaer, M.C.C. Jansen, H.A.M. Kerstjens, and F.F.H. Rutten (1995). Costs and effects of inhaled corticosteroids and bronchodilators in asthma and chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 151, 975–982.
Connett, G.J., W. Lenney, and S.M. McConchie (1993). The cost-effectiveness of budesonide in severe asthmatics aged one to three years. British Journal of Medical Economics, 6, 127–270.
Gold, M.R., J.E. Siegel, L.B. Russel, and M.C. Weinstein, Eds. (1996). Report of the Panel on Cost-effectiveness in Health and Medicine. Cost-Effectiveness in Health and Medicine. Oxford University Press, New York.
Kuntz, K.M., B.T. Kitch, A.L. Fuhlbrigge, A.D. Paltiel, P.J. Neumann, and S.T. Weiss (2002). A novel approach to defining the relationship between lung function and symptom status in asthma. Journal of Clinical Epidemiology, 55, 11–18.
Fuhlbrigge, A.L., B.T. Kitch, A.D. Paltiel, K.M. Kuntz, P.J. Neumann, D.W. Dockery, and S.T. Weiss (2001). FEV1 is associated with risk of asthma attacks in a pediatric population. Journal of Allergy and Clinical Immunology, 107, 61–67.
Neumann, P.J., K. Blumenschein, A. Zillich, M. Johannesson, K.M. Kuntz, R.H. Chapman, S.T. Weiss, B.T. Kitch, A.L. Fuhlbrigge, and A.D. Paltiel (2000). Relationship between FEV1% predicted and utilities in adult asthma [Abstract]. Medical Decision Making, 20, 488.
Paltiel, A.D., A.L. Fuhlbrigge, B.T. Kitch, B. Liljas, S.T. Weiss, P.J. Neumann, and K.M. Kuntz (2001). Cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: Results from the Asthma Policy Model. Journal of Allergy and Clinical Immunology, 108, 39–46.
Sullivan, S.D., A. Elixhauser, A.S. Buist, B.R. Luce, J. Eisenberg, and K.B. Weiss (1996). National Asthma Education and Prevention Program working group report on the cost-effectiveness of asthma care. American Journal of Respiratory and Critical Care Medicine, 154, S84–S95.
United States Bureau of the Census (1998). Statistical Abstract of the United States: 1998. Washington, DC.
Beck, J.R. and S.G. Pauker (1983). The Markov process in medical prognosis. Medical Decision Making, 3, 419–458.
Sonnenberg, F.A. and J.R. Beck (1993). Markov models in medical decision making: a practical guide. Medical Decision Making, 13, 322–338.
Crane, J., N. Pearce, C. Burgess, K. Woodman, B. Robson, and R. Beasley (1992). Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma. International Journal of Epidemiology, 21, 737–744.
Ortega, A.N., K.D. Belanger, M.B. Bracken, and B.P. Leaderer (2001). A childhood asthma severity scale: symptoms, medications, and health care visits. Annals of Allergy, Asthma, and Immunology, 86, 405–413.
National Asthma Education and Prevention Program (1991). Guidelines for the Diagnosis and Management of Asthma. Expert Panel Report. U.S. Department of Health and Human Services, Washington, DC, Publication # 91-3042.
Enright, P.L., M.D. Lebowitz, and D.W. Cockroft (1994). Physiologic measures: pulmonary function tests. Asthma outcomes. American Journal of Respiratory and Critical Care Medicine, 149, S9–S20.
Enright, P.L., L.R. Johnson, J.E. Connett, H. Voelker, and A.S. Buist (1991). Spirometry in the Lung Health Study. Methods and quality control. American Review of Respiratory Disease, 143, 1215–1221.
Kitch, B.T., A.L. Fuhlbrigge, K.M. Kuntz, P.J. Neumann, A.D. Paltiel, B. Rijeken, B. Schouten, D.S. Postma, and S.T. Weiss (1999). Relationship between FEV1 and subsequent asthma attacks. American Journal of Respiratory and Critical Care Medicine, 159, A135.
Thomas, P., R.N. Ross, and J.R. Farrar (1996). A retrospective assessment of cost avoidance associated with the use of nedocromil sodium metered-dose inhaler in the treatment of patients with asthma. Clinical Therapeutics, 18, 939–952.
Donahue, J.G., S.T. Weiss, J.M. Livingston, M.A. Goetsch, D.K. Greineder, and R. Platt (1997). Inhaled steroids and the risk of hospitalization for asthma. Journal of the American Medical Association, 277, 887–891.
Finkelstein, J.A., M.B. Barton, J.G. Donahue, P. Algatt-Bergstrom, L.E. Markson, and R. Platt (2000). Comparing asthma care for Medicaid and non-Medicaid children in an HMO. Archives of Pediatrics and Adolescent Medicine, 154, 563–568.
Rutten-van-Molken, M.P.M.H., E.K.A. Van Doorslaer, M.C.C. Jansen, H.A.M. Kerstjens, and F.F.H. Rutten (1995). Costs and effects of inhaled corticosteroids and bronchodilators in asthma and chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 151, 975–982.
Revicki, D.A., N.K. Leidy, F. Brennan-Diemer, S. Sorensen, and A. Togias (1998). Integrating patient preferences into health outcomes assessment: the multiattribute Asthma Symptom Utility Index. Chest, 114, 998–1007.
Neumann, P.J., K. Blumenschein, A. Zillich, M. Johannesson, K.M. Kuntz, R.H. Chapman, S.T. Weiss, B.T. Kitch, A.L. Fuhlbrigge, and A.D. Paltiel (2000). Relationship between FEV1% predicted and utilities in adult asthma. Medical Decision Making, 20, 488.
Pearlman, D.S., W. Stricker, S. Weinstein, G. Gross, P. Chervisnsky, A. Woodring, B. Prillaman, and T. Shah (1999). Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma. Annals of Allergy, Asthma, and Immunology, 82, 257–265.
Noonan, M., P. Chervinsky, W.W. Busse, S.C. Weisberg, J. Pinna, B.P. de Boisblanc, H. Boltansky, D. Pearlman, L. Rephser, D. Kellerman (1995). Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life. American Journal of Respiratory and Critical Care Medicine, 152, 1467–1473.
Bel, E.H., M.C. Timmers, J. Hermans, J.H. Dijkman, and P.J. Sterk (1990). The long-term effects of nedocromil sodium and beclomethasone dipropionate on bronchial responsiveness to methacholine in nonatopic asthmatic subjects. American Review of Respiratory Disease, 141, 21–28.
Fahy, J.V. and H.A. Boushey (1998). Effect of low-dose beclomethasone dipropionate on asthma control and airway inflammation. European Respiratory Journal, 11(6), 1240–1247.
Galant, S.P., M. Lawrence, E.O. Meltzer, M. Tomasko, K.A. Baker, and D.J. Kellerman (1996). Fluticasone propionate compared with theophylline for mild-to-moderate asthma. Annals of Allergy, Asthma, and Immunology, 77, 112–118.
Kemp, J., A.A. Wanderer, J. Ramsdell, D.L. Southern, S. Weiss, D. Aaronson, and J. Grossman (1999). Rapid onset of control with budesonide Turbuhaler in patients with mild-to-moderate asthma. Annals of Allergy, Asthma, and Immunology, 82, 463–471.
Li, J.T., L.B. Ford, P. Chervinsky, S.C. Weisberg, D.J. Kellerman, K.G. Faulkner, N.E. Herje, A. Hamedani, S.M. Harding, and T. Shah (1999). Fluticasone propionate powder and lack of clinically significant effects on hypothalamic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthma. Journal of Allergy and Clinical Immunology, 103, 1062–1068.
McFadden, E.R., T.B. Casale, T.B. Edwards, J.P. Kemp, W.J. Metzger, H.S. Nelson, W.W. Storms, and M.J. Neidl (1999). Administration of budesonide once daily by means of turbuhaler to subjects with stable asthma. Journal of Allergy and Clinical Immunology, 104, 46–52.
Meltzer, E.O., H.A. Orgel, E.F. Ellis, H.N. Eigen, and M.P. Hemstreet (1992). Long-term comparison of three combinations of albuterol, theophylline, and beclomethasone in children with chronic asthma. Journal of Allergy and Clinical Immunology, 90, 2–11.
Nathan, R.A., J.L. Pinnas, H.J. Schwartz, J. Grossman, S.W. Yancey, A.H. Emmett, and K.A. Rickard (1999). A six-month, placebo-controlled comparison of the safety and efficacy of salmeterol or beclomethasone for persistent asthma. Annals of Allergy, Asthma, and Immunology, 82, 521–529.
Osterman, K., M. Carlholm, J. Ekelund, J. Kiviloog, K. Nikander, L. Nilholm, P. Salomonsson, V. Strand, P. Venge, and O. Zetterstrom (1997). Effect of 1 year daily treatment with 400 microg budesonide (Pulmicort Turbuhaler) in newly diagnosed asthmatics. European Respiratory Journal, 10, 2210–2215.
Peden, D.B., W.E. Berger, M.J. Noonan, M.J. Noonan, M.R. Thomas, V.L. Hendricks, A.G. Hamedani, P. Mahajan, and K.W. House (1998). Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma. Journal of Allergy and Clinical Immunology, 102, 32–38.
Reed, C.E., K.P. Offord, H.S. Nelson, J.T. Li, and D.G. Tinkelman (1998). Aerosol beclomethasone dipropionate spray compared with theophylline as primary treatment for chronic mild-to-moderate asthma. The American Academy of Allergy, Asthma and Immunology Beclomethasone Dipropionate-Theophylline Study Group. Journal of Allergy and Clinical Immunology, 101, 14–23.
Sheffer, A.L., C. LaForce, P. Chervinsky, D. Pearlman, and A. Schaberg (1996). Fluticasone propionate aerosol: efficacy in patients with mild to moderate asthma. Fluticasone Propionate Asthma Study Group. Family Practice, 42, 369–375.
Simons, F.E. (1997). A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group. New England Journal of Medicine, 337, 1659–1665.
Tinkelman, D.G., C.E. Reed, H.S. Nelson, and K.P. Offord (1993). Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. Pediatrics, 92, 64–77.
Evans, R. 3rd, D.I. Mullally, R.W. Wilson, P. J. Gergen, H.M. Rosenberg, J.S. Grauman, F.M. Chevarley, and M. Feinleib (1987). National Trends in Morbidity and Mortality of Asthma in the US. Chest, 91, 65S–73S.
U.S. Bureau of the Census (1997). Statistical Abstract of the United States: 1997. Washington, DC.
Serra-Batlles, J., V. Plaza, E. Morejon, A. Comella, and J. Brugues (1998). Costs of asthma according to the degree of severity. European Respiratory Journal, 12, 1322–1326.
Stanford, R., T. McLaughlin, and L.J. Okamoto (1999). The cost of asthma in the emergency department and hospital. American Journal of Respiratory and Critical Care Medicine, 160, 211–215.
Lewis, C.E., G. Rachelefsky, M.A. Lewis, A. de la Sota, and M. Kaplan (1984). A randomized trial of A.C.T. (asthma care training) for kids. Pediatrics, 74, 478–486.
Ross, R.N., M. Morris, S.R. Sakowitz, and B.A. Berman (1988). Cost-effectiveness of including cromolyn sodium in the treatment program for asthma: a retrospective, record-based study. Clinical Therapeutics, 10, 188–203.
Weiss, K.B., P.J. Gergen, and T.A. Hodgson (1992). An economic evaluation of asthma in the United States. New England Journal of Medicine, 326, 862–866.
Coventry, J.A., M.S. Weston, and P.M. Collins (1996). Emergency room encounters of pediatric patients with asthma: cost comparisons with other treatment settings. Journal of Ambulatory Care Management, 19, 9–21
Segal, R., L.D. Ried, and J. Mackowiak (1995). Cost of asthma illness: Emergency department visits without admission. Pharmacy Practice Management Quarterly, 15, 72–82.
Barnes, P.J., S. Pedersen, and W.W. Busse (1993). Efficacy and safety of inhaled corticosteroids. New developments. American Journal of Respiratory and Critical Care Medicine, 157, S1–S53.
O’Byrne, P.M. and S. Pedersen (1998). Measuring efficacy and safety of different inhaled corticosteroid preparations. Journal of Allergy and Clinical Immunology, 102, 879–886.
Chapman, R.H., P.W. Stone, E.A. Sandberg, C. Bell, and P.J. Neumann (2000). A comprehensive league table of cost-utility ratios and a sub-table of “panel-worthy” studies. Medical Decision Making, 20, 451–467.
Sippel, J.M., K.L. Pudula, W.M. Vollmer, A.S. Buist, and M.L. Osborne (1999). Association of smoking with hospital-based care and quality of life in patients with obstructive airway disease. Chest, 115, 691–696.
Prescott, E., P. Lange, and J. Vestbo (1997). Effect of gender on hospital admission for asthma and prevalence of self-reported asthma: a prospective study based on a sample of the general population. Copenhagen City Health Study Group. Thorax, 52, 287–289.
Lange, P., J. Parner, J. Bestbro, P. Schnohr, and G. Jensen (1998). A 15 year follow up study of ventilatory function in adults with asthma. New England Journal of Medicine, 339, 1194–1200.
Ulrik, C.S. and P. Lange (1994). Decline of Lung Function in Adults with Bronchial Asthma. American Journal of Respiratory and Critical Care Medicine, 150, 629–634.
Cook, D.G. and D.P. Strachan (1999). Health effects of passive smoking-10: Summary of effects of parental smoking on the respiratory health of children and implications for research. Thorax, 54, 357–366.
Toogood, J.H., A.E. Markov, J. Baskerville, and C. Dyson (1993). Association of ocular cataracts with inhaled and oral steroid therapy during long-term treatment of asthma. Journal of Allergy and Clinical Immunology, 91, 571–579.
Toogood, J.H. (1998). Inhaled steroid asthma treatment: ‘Primum non nocere’. Canadian Respiratory Journal, 5, 50A–53A.
Niewoehner, C.B. and D.E. Niewoehner (1999). Steroid-induced osteoporosis. Are your asthmatic patients at risk? Postgraduate Medicine, 105, 79–83, 87–8, 91.
Christensen-Szalanski, J.J. and G.B. Northcraft (1985). Patient compliance behavior: the effect of time on patients’ valued of treatment regiments. Social Science and Medicine, 21, 263–273.
Greenburg, R.N. (1984). Overview of patient compliance with medication dosing: a literature review. Clinical Therapeutics, 6, 592–599.
Donahue, J.G., S.T. Weiss, J.M. Livingston, M.A. Goetsch, D.K. Greineder, and R. Platt (1997). Inhaled steroids and the risk of hospitalization for asthma. Journal of the American Medical Association, 277, 887–891.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science + Business Media, Inc.
About this chapter
Cite this chapter
Paltiel, A.D., Kuntz, K.M., Weiss, S.T., Fuhlbrigge, A.L. (2005). An Asthma Policy Model. In: Brandeau, M.L., Sainfort, F., Pierskalla, W.P. (eds) Operations Research and Health Care. International Series in Operations Research & Management Science, vol 70. Springer, Boston, MA. https://doi.org/10.1007/1-4020-8066-2_26
Download citation
DOI: https://doi.org/10.1007/1-4020-8066-2_26
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4020-7629-9
Online ISBN: 978-1-4020-8066-1
eBook Packages: Springer Book Archive